合成路线1
该中间体在本合成路线中的序号:
(I) Antineopleston A10 (A10) can be obtained by two different ways:
1) A10 has been synthesized in two steps: Condensation of phenylacetic acid (I) with L-glutamine (V) to give phenylacetyl-L-glutamine (VI), followed by intramolecular cyclization of the latter. In the first step (I) is activated by reacting with various reagents such as HOSu (N-hydroxysuccinimide) (II) in the presence of DCC, DCC (N,N-dicyclohexylcarbodiimide) or 2-mercaptothiazoline (III) in the presence of DCC to afford the intermediates (IVa), (IVb) and (IVc), respectively. Without isolation, the intermediate (IVa), (IVb) or (IVc) is treated with a solution of L-glutamine in CH3CN:H2O (2:1) containing NaHCO3 to give (VI) in 60, 87 and 82% yields, respectively. In the second step (VI) is converted to the activated intermediate (IXa) or (IXb) by treatment with CDI (1,1'-carbonydiimidazole) (VII) or HOSu (VIII) in the presence of DCC. Finally, intramolecular cyclization of (IXa) or (IXb) is effected by treating the latter at 80 C to yield A10 in 85 or 82% yield, respectively.
2) Reaction of phenylacetyl chloride with L-glutamine in aqueous solution containing NaHCO3 affords phenylacetyl-L-glutamine (VI), which is heated at 160 C to give A10.
【1】
Verhoef, J.; Schmitz, F.-J.; Fluit, A.C.; Milatovic, D.; 13th Intl Cong Chemother (Aug. 28-Sept. 2, Vienna) 1983, 50, 2, PS 12.4-11-4.
|
【2】
Burzynski, S.R. (Burzynski Research Institute); Purified antineoplaston factions and methods of treating neoplastic disease. EP 0069232; JP 5032548; JP 5058886; JP 58010521; US 4470970 .
|
【3】
Burzynski, S.R.; Hai, T.T.; Antineoplaston A10. Drugs Fut 1985, 10, 2, 103.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10101 |
Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene
|
501-53-1 |
C8H7ClO2 |
详情 | 详情
|
(IVa) |
24947 |
1-[(2-phenylacetyl)oxy]-2,5-pyrrolidinedione
|
|
C12H11NO4 |
详情 |
详情
|
(IVb) |
28896 |
phenylacetic anhydride
|
|
C16H14O3 |
详情 |
详情
|
(IVc) |
28897 |
2-phenyl-1-(2-thioxo-1,3-thiazolidin-3-yl)-1-ethanone
|
|
C11H11NOS2 |
详情 |
详情
|
(IXa) |
28899 |
(3S)-4-(1H-imidazol-1-yl)-4-oxo-3-[(2-phenylacetyl)amino]butanamide
|
|
C15H16N4O3 |
详情 |
详情
|
(IXb) |
28900 |
(3S)-4-[(2,5-dioxo-1-pyrrolidinyl)oxy]-4-oxo-3-[(2-phenylacetyl)amino]butanamide
|
|
C16H17N3O6 |
详情 |
详情
|
(I) |
16148 |
Benzeneacetic acid; 2-Phenylacetic acid; Phenyl Acetic Acid
|
103-82-2 |
C8H8O2 |
详情 | 详情
|
(II) |
10264 |
1-Hydroxydihydro-1H-pyrrole-2,5-dione; N-Hydroxysuccinimide; 1-Hydroxy-2,5-pyrrolidinedione
|
6066-82-6 |
C4H5NO3 |
详情 | 详情
|
(III) |
28895 |
4,5-dihydro-1,3-thiazol-2-ylhydrosulfide
|
96-53-7 |
C3H5NS2 |
详情 | 详情
|
(V) |
24948 |
L-glutamine
|
56-85-9 |
C5H10N2O3 |
详情 | 详情
|
(VI) |
28898 |
(2S)-4-amino-4-oxo-2-[(2-phenylacetyl)amino]butyric acid
|
|
C12H14N2O4 |
详情 |
详情
|
(VII) |
11353 |
1,1'-Carbonyldiimidazole; Di(1H-imidazol-1-yl)methanone; N,N-Carbonyldiimidazole; 1,1'-Carbonylbis(1H-imidazole)
|
530-62-1 |
C7H6N4O |
详情 | 详情
|
(VIII) |
10264 |
1-Hydroxydihydro-1H-pyrrole-2,5-dione; N-Hydroxysuccinimide; 1-Hydroxy-2,5-pyrrolidinedione
|
6066-82-6 |
C4H5NO3 |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(I) Antineoplaston AS2-5 (AS2-5) can be obtained in the following way (1,2): N-Phenylacetyl-L-glutamine sodium is synthesized in two steps. In the first step, phenylacetic acid (I) is treated with N-hydroxysuccinimide (B) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (A) in acetonitrile to give intermediate (Ia). In the second step, (Ia) is reacted without purification with L-glutamine (II) in the presence of NaHCO3 in 1:1 acetonitrile-water mixture to afford N-phenylacetyl-L-glutamine (III) in 87% yield. Compound (III) is then converted to sodium salt in aqueous solution by treatment with aqueous sodium hydroxide solution (pH 7).
In a large scale preparation reaction of phenylacetyl chloride with L-glutamine in aqueous solution containing NaHCO3 affords N-phenyiacetyl L-glutamine sodium.
【1】
Burzynski, S.R. (Burzynski Research Institute); Purified antineoplaston fractions and methods of treating neoplastic disease. US 4558057 .
|
【2】
Berman, E.M.; Gregor, V.E.; Showalter, H.H.D. (Pfizer Inc.); Benzoselenino[4,3,2-cd]indazole compound, compositions comprising the compounds and processes for producing the compounds. AU 8544154; EP 0170412; ES 8704956 .
|
【3】
Khalid, M.; Burzynski, S.R.; Antineoplaston AS2-5. Drugs Fut 1986, 11, 5, 364.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
10264 |
1-Hydroxydihydro-1H-pyrrole-2,5-dione; N-Hydroxysuccinimide; 1-Hydroxy-2,5-pyrrolidinedione
|
6066-82-6 |
C4H5NO3 |
详情 | 详情
|
(Ia) |
24927 |
tert-butyl (2R,3aR,7aR,10aR)-8-(dimethoxymethyl)-5-(5-hexenyl)-10-oxo-2-vinyl-2,3,5,6,7,7a,10,10a-octahydropyrrolo[2,3-i]isoquinoline-1(4H)-carboxylate
|
|
C27H42N2O5 |
详情 |
详情
|
(A) |
24945 |
N-[3-(dimethylamino)propyl]-N'-ethylcarbodiimide
|
25952-53-8 |
C8H17N3 |
详情 | 详情
|
(I) |
16148 |
Benzeneacetic acid; 2-Phenylacetic acid; Phenyl Acetic Acid
|
103-82-2 |
C8H8O2 |
详情 | 详情
|
(II) |
24948 |
L-glutamine
|
56-85-9 |
C5H10N2O3 |
详情 | 详情
|
(III) |
24949 |
(2S)-5-amino-5-oxo-2-[(2-phenylacetyl)amino]pentanoic acid
|
|
C13H16N2O4 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(I) The alkylation of 2-phenylacetic acid (I) with 2-chloroethyl(methyl)sulfide (II) by means of lithium diisopropylamide (LDA) in THF gives 4-(methylsulfanyl)-2-phenylbutyric acid (III), which is esterified with methanol/H2SO4 yielding the methyl ester (IV). The transesterification of (IV) with quinuclidin-3(R)-ol (V) by means of NaH in refluxing toluene affords the 3(R)-quinuclidinyl ester (VI), which is hydroxymethylated with paraformaldehyde and NaH in DMF giving 2(RS)-(hydroxymethyl)-4-(methylsulfanyl)-2-phenylbutyric acid 3(R)-quinuclidinyl ester (VII) as a diastereomeric mixture. Chromatographic separation of (VII) over SiO2 using CHCl3/methanol/NH4OH as a gradient elution yields the 2(S)-hydroxymethyl isomer (VIII), which is oxidized with trifluoroperacetic acid in trifluoroacetic acid affording the corresponding sulfinyl derivative (IX) as a new diastereomeric mixture. Finally, this mixture is resolved by HPLC over Kromasil C-8 SiO2 using as eluant water/acetonitrile containing 1% trifluoroacetic acid.
【1】
Martel, A.M.; Rabasseda, X.; Castaner, J.; Revatropate. Drugs Fut 1997, 22, 2, 135.
|
【2】
Cross, P.E.; Stobie, A. (Pfizer Inc.); Quinuclidine esters process and intermediate for their preparation and pharmaceutical compsns. containing them. EP 0603229; JP 1994510991; JP 1997315970; WO 9306098 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16148 |
Benzeneacetic acid; 2-Phenylacetic acid; Phenyl Acetic Acid
|
103-82-2 |
C8H8O2 |
详情 | 详情
|
(II) |
16149 |
2-Chloroethyl methyl sulfide; 1-Chloro-2-(methylsulfanyl)ethane
|
542-81-4 |
C3H7ClS |
详情 | 详情
|
(III) |
16150 |
4-(methylsulfanyl)-2-phenylbutyric acid
|
|
C11H14O2S |
详情 |
详情
|
(IV) |
16151 |
methyl 4-(methylsulfanyl)-2-phenylbutanoate
|
|
C12H16O2S |
详情 |
详情
|
(V) |
16152 |
(3R)-1-azabicyclo[2.2.2]octan-3-ol; (R)-(-)-Quinuclidinol
|
42437-96-7 |
C7H13NO |
详情 | 详情
|
(VI) |
16153 |
(3R)-1-azabicyclo[2.2.2]oct-3-yl 4-(methylsulfanyl)-2-phenylbutanoate
|
|
C18H25NO2S |
详情 |
详情
|
(VII) |
16154 |
(3R)-1-azabicyclo[2.2.2]oct-3-yl 2-(hydroxymethyl)-4-(methylsulfanyl)-2-phenylbutanoate
|
|
C19H27NO3S |
详情 |
详情
|
(VIII) |
16155 |
(3R)-1-azabicyclo[2.2.2]oct-3-yl (2S)-2-(hydroxymethyl)-4-(methylsulfanyl)-2-phenylbutanoate
|
|
C19H27NO3S |
详情 |
详情
|
(IX) |
16156 |
(3R)-1-azabicyclo[2.2.2]oct-3-yl (2S)-2-(hydroxymethyl)-4-(methylsulfinyl)-2-phenylbutanoate
|
|
C19H27NO4S |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(I) The synthesis of rofecoxib can be performed by several different ways:
1) The condensation of phenylacetic acid (I) with ethyl bromoacetate (II) by means of triethylamine in THF yields 2-(phenylacetoxy)acetic acid ethyl ester (III), which is cyclized to the hydroxyfuranone (IV) by means of potassium tert-butoxide in tert-butanol. The reaction of (IV) with triflic anhydride and diisopropylethylamine in dichloro-methane affords the corresponding triflate (V), which by reaction with LiBr in hot acetone yields the bromofuranone (VI). The condensation of (VI) with 4-(methylsulfanyl)phenylboronic acid (VII) by means of Na2CO3 and Pd(Ph3P)4 in hot toluene gives 4-[4-(methylsulfanyl)-phenyl]-3-phenylfuran-2(5H)-one (VIII), which is finally oxidized with 2KHSO5.KHSO4.K2SO4 (oxone).
2) The intermediate (VIII) can also be obtained by condensation of triflate (V) with boronic acid (VII) by means of Na2CO3 and Pd(Ph3P)4 in hot toluene.
3) The intermediate (VIII) can also be synthesized by the reaction of triflate (V) with tetramethylammonium chloride, giving the chlorofuranone (IX), which is then condensed with boronic acid (VII) as before.
【1】
Sorbera, L.A.; Rabasseda, X.; Castañer, J.; Rofecoxib. Drugs Fut 1998, 23, 12, 1287.
|
【2】
Tillyer, R.; Desmond, R.; Dolling, U.; Marcune, B.; Tschaen, D. (Merck & Co., Inc.); Process for making phenyl heterocycles useful as COX-2 inhibitors. WO 9608482 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16148 |
Benzeneacetic acid; 2-Phenylacetic acid; Phenyl Acetic Acid
|
103-82-2 |
C8H8O2 |
详情 | 详情
|
(II) |
16640 |
Ethyl 2-bromoacetate; Ethyl bromoacetate
|
105-36-2 |
C4H7BrO2 |
详情 | 详情
|
(III) |
19255 |
2-ethoxy-2-oxoethyl 2-phenylacetate
|
|
C12H14O4 |
详情 |
详情
|
(IV) |
19256 |
4-hydroxy-3-phenyl-2(5H)-furanone
|
23782-85-6 |
C10H8O3 |
详情 | 详情
|
(V) |
19257 |
5-oxo-4-phenyl-2,5-dihydro-3-furanyl trifluoromethyl sulfate
|
|
C11H7F3O6S |
详情 |
详情
|
(VI) |
19258 |
4-bromo-3-phenyl-2(5H)-furanone
|
|
C10H7BrO2 |
详情 |
详情
|
(VII) |
18561 |
4-(methylsulfanyl)phenylboronic acid
|
98546-51-1 |
C7H9BO2S |
详情 | 详情
|
(VIII) |
19260 |
4-[4-(methylsulfanyl)phenyl]-3-phenyl-2(5H)-furanone
|
|
C17H14O2S |
详情 |
详情
|
(IX) |
19261 |
4-chloro-3-phenyl-2(5H)-furanone
|
|
C10H7ClO2 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(I) 4) The oxidation of 4-(methylsulfanyl)acetophenone (X) with monoperoxyphthalic acid (MMPP) in dichloro-methane/methanol gives the corresponding sulfone (XI), which is brominated with Br2/AlCl3 in chloroform, yielding the expected phenacyl bromide (XII). Finally, this compound is cyclocondensed with phenylacetic acid (I) by means of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) and triethylamine in acetonitrile.
5) Reaction of [4-(methylsulfonyl)phenyl]phenylacetyl-ene (XIII) with CO catalyzed by Rh4(CO)12 in THF at 100 C in a stainless steel autoclave at 100 Atm pressure, followed by a chromatographic separation in a silicagel column to eliminate the undesired regioisomer.
【1】
Sorbera, L.A.; Rabasseda, X.; Castañer, J.; Rofecoxib. Drugs Fut 1998, 23, 12, 1287.
|
【2】
Atkinson, J.G.; Wang, Z. (Merck Frosst Canada Inc.); Stilbene derivs. useful as cyclooxygenase-2 inhibitors. EP 0788476; JP 1998507765; WO 9613483 .
|
【3】
Ducharme, Y.; Gauthier, J.Y.; Prasit, P.; Leblanc, Y.; Wang, Z.; Leger, S.; Therien, M. (Merck Frosst Canada Inc.); Phenyl heterocycles as cyclooxygenase-2 inhibitors. EP 0705254; EP 0739340; EP 0754687; EP 0822190; EP 0980866; JP 1997500372; JP 1997506631; JP 2000038375; US 5474995; WO 9500501; WO 9518799 . |
【4】
Hancock, B.; Winters, C.; Gertz, B.; Ehrich, E. (Merck & Co., Inc.; Merck Frosst Canada Inc.); Compsns. for a once a day treatment of cyclooxygenase-2 mediated diseases. JP 1999512754; WO 9744028 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16148 |
Benzeneacetic acid; 2-Phenylacetic acid; Phenyl Acetic Acid
|
103-82-2 |
C8H8O2 |
详情 | 详情
|
(X) |
19262 |
1-[4-(methylsulfanyl)phenyl]-1-ethanone;4'-Methylthioacetophenon;4’-(methylthio)acetophenone |
1778-09-2 |
C9H10OS |
详情 | 详情
|
(XI) |
19263 |
1-[4-(methylsulfonyl)phenyl]-1-ethanone; 4-methylsulfonylacetophenone
|
10297-73-1 |
C9H10O3S |
详情 | 详情
|
(XII) |
19264 |
2-bromo-1-[4-(methylsulfonyl)phenyl]-1-ethanone
|
|
C9H9BrO3S |
详情 |
详情
|
(XIII) |
19265 |
methyl 4-(2-phenylethynyl)phenyl sulfone; methyl(dioxo)[4-(2-phenylethynyl)phenyl]-lambda(6)-sulfane
|
|
C15H12O2S |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(VI) The Friedel Crafts acylation of thioanisole (I) with acetyl chloride (II) and AlCl3 in chloroform gives 4-(methylsulfanyl)acetophenone (III), which is oxidized with monoperoxyphthalic acid (MMPP) in methanol/dichloromethane to yield 4-(methylsulfonyl)acetophenone (IV). The bromination of (IV) with Br2 and AlCl3 in chloroform affords 4-(methylsulfonyl)phenacyl bromide (V), which is finally cyclized by means of DBU and TEA in acetonitrile to provide the target furanone derivative.
【1】
Thérien, M.; Gauthier, J.Y.; Leblanc, Y.; Leger, S.; Perrier, H.; Prasit, P.; Wang, Z.; Synthesis of rofecoxib, (MK 0966, Vioxx(R)) 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone), a selective and orally active inhibitor of cyclooxygenase-2. Synthesis (Stuttgart) 2001, 12, 1778. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19272 |
methyl phenyl sulfide; 1-(methylsulfanyl)benzene
|
100-68-5 |
C7H8S |
详情 | 详情
|
(II) |
19273 |
acetyl chloride
|
75-36-5 |
C2H3ClO |
详情 | 详情
|
(III) |
19262 |
1-[4-(methylsulfanyl)phenyl]-1-ethanone;4'-Methylthioacetophenon;4’-(methylthio)acetophenone |
1778-09-2 |
C9H10OS |
详情 | 详情
|
(IV) |
19263 |
1-[4-(methylsulfonyl)phenyl]-1-ethanone; 4-methylsulfonylacetophenone
|
10297-73-1 |
C9H10O3S |
详情 | 详情
|
(V) |
19264 |
2-bromo-1-[4-(methylsulfonyl)phenyl]-1-ethanone
|
|
C9H9BrO3S |
详情 |
详情
|
(VI) |
16148 |
Benzeneacetic acid; 2-Phenylacetic acid; Phenyl Acetic Acid
|
103-82-2 |
C8H8O2 |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
(XI) Condensation of phenylacetic acid (XI) with methoxyamine gave hydroxamate (XII). After N-chlorination of (XII) with tert-butyl hypochlorite, Ag(I)-catalyzed ring closure of the intermediate (XIII) produced N-(methoxy)oxindole (XIV). Amide reduction of (XIV) with LiAlH4 gave hemiaminal (XV), which was converted to the racemic tryptophan derivative (XVII) by reaction with alpha-acetamidoacrylic acid (XVI) in AcOH-Ac2O. Optical resolution of (XVII) by enantioselective enzymatic hydrolysis of the acetamide group using Acylase I from Aspergillus sp. afforded N1'-methoxy-L-tryptophan (XVIII), which was protected as the N-Boc derivative (XIX) and N-methylated by means of MeI and NaH yielding (XX). The resulting N-methyl amino acid (XX) was esterified upon treatment with (trimethylsilyl)diazomethane giving (XXI), and the N-Boc group was removed with HCl in EtOAc to provide the tryptophan derivative (XXII).
【1】
Boger, D.L.; et al.; Total synthesis of HUN-7293. J Am Chem Soc 1999, 121, 26, 6197.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
15455 |
(aminooxy)methane; O-methylhydroxylamine
|
67-62-9 |
CH5NO |
详情 | 详情
|
(XI) |
16148 |
Benzeneacetic acid; 2-Phenylacetic acid; Phenyl Acetic Acid
|
103-82-2 |
C8H8O2 |
详情 | 详情
|
(XII) |
26273 |
N-methoxy-2-phenylacetamide
|
|
C9H11NO2 |
详情 |
详情
|
(XIII) |
26274 |
N-chloro-N-methoxy-2-phenylacetamide
|
|
C9H10ClNO2 |
详情 |
详情
|
(XIV) |
26275 |
1-methoxy-1,3-dihydro-2H-indol-2-one
|
|
C9H9NO2 |
详情 |
详情
|
(XV) |
26276 |
1-methoxy-2-indolinol
|
|
C9H11NO2 |
详情 |
详情
|
(XVI) |
26277 |
2-(acetamido)acrylic acid
|
5429-56-1 |
C5H7NO3 |
详情 | 详情
|
(XVII) |
26278 |
N-acetyl-1-methoxytryptophan
|
|
C14H16N2O4 |
详情 |
详情
|
(XVIII) |
26279 |
(2S)-2-amino-3-(1-methoxy-1H-indol-3-yl)propionic acid
|
|
C12H14N2O3 |
详情 |
详情
|
(XIX) |
26280 |
(2S)-2-[(tert-butoxycarbonyl)amino]-3-(1-methoxy-1H-indol-3-yl)propionic acid
|
|
C17H22N2O5 |
详情 |
详情
|
(XX) |
26281 |
(2S)-2-[(tert-butoxycarbonyl)(methyl)amino]-3-(1-methoxy-1H-indol-3-yl)propionic acid
|
|
C18H24N2O5 |
详情 |
详情
|
(XXI) |
26282 |
methyl (2S)-2-[(tert-butoxycarbonyl)(methyl)amino]-3-(1-methoxy-1H-indol-3-yl)propanoate
|
|
C19H26N2O5 |
详情 |
详情
|
(XXII) |
26283 |
methyl (2S)-3-(1-methoxy-1H-indol-3-yl)-2-(methylamino)propanoate
|
|
C14H18N2O3 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(II) Coumarin (III) was prepared by condensation of benzophenone (I) with phenylacetic acid (II) in the presence of Ac2O and Et3N. Reduction of the lactone function of (III) with LiAlH4, followed by acidic treatment furnished diaryl chromene (IV). Subsequent hydrogenation of (IV) over Pd/C gave rise to the racemic cis chromane (V), which was O-alkylated with 1-(2-chloroethyl) pyrrolidine (VI) producing the corresponding (pyrrolidinyl)ethoxy derivative. Resolution by means of active ditoluoyl tartaric acid yielded the desired (-)-enantiomer (VII). Finally, cleavage of the methoxy group using pyridine hydrochloride at 150 C provided the title compound.
【1】
Bury, P.S.; et al.; Synthesis and pharmacological evaluation of novel cis-3,4-diaryl-hydroxychromanes as high affinity partial agonists for the estrogen receptor. Bioorg Med Chem 2002, 10, 1, 125.
|
【2】
Jacobsen, P.; Treppendahl, S.; Stanley Bury, P.; Kanstrup, A.; Brown Christiansen, L. (Novo Nordisk A/S); Novel cis-3,4-chroman derivs. useful in the prevention or treatment of estrogen related diseases or syndromes. EP 0937060; WO 9818776 .
|
【3】
Jacobsen, P.; Treppendahl, S.; Stanley Bury, P.; Kanstrup, A.; Brown Christiansen, L. (Novo Nordisk A/S); Novel (-)-enantiomers of cis-3,4-chroman derivs. useful in the prevention or treatment of estrogen related diseases or syndromes. EP 0937057; WO 9818771 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
35211 |
(2-hydroxy-4-methoxyphenyl)(4-hydroxyphenyl)methanone
|
|
C14H12O4 |
详情 |
详情
|
(II) |
16148 |
Benzeneacetic acid; 2-Phenylacetic acid; Phenyl Acetic Acid
|
103-82-2 |
C8H8O2 |
详情 | 详情
|
(III) |
35212 |
4-(7-methoxy-2-oxo-3-phenyl-2H-chromen-4-yl)phenyl acetate
|
|
C24H18O5 |
详情 |
详情
|
(IV) |
35213 |
4-(7-methoxy-3-phenyl-2H-chromen-4-yl)phenol
|
|
C22H18O3 |
详情 |
详情
|
(V) |
35214 |
4-[(3S,4R)-7-methoxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenol
|
|
C22H20O3 |
详情 |
详情
|
(VI) |
33922 |
1-(2-Chloroethyl)pyrrolidine; N-(2-Chloroethyl)pyrrolidine
|
|
C6H12ClN |
详情 |
详情
|
(VII) |
35215 |
1-(2-[4-[(3S,4R)-7-methoxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenoxy]ethyl)pyrrolidine; 4-[(3S,4R)-7-methoxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenyl 2-(1-pyrrolidinyl)ethyl ether
|
|
C28H31NO3 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(XI) The starting product dibenzo[a,d]cyclohepta-1,4,6-triene-5-one (I) is prepared by condensation of phthalic anhydride (X) with phenylacetic acid (XI) by means of sodium acetate at 240 C that gives benzalphthalide (XII). This compound is reduced with red phosphorus in refluxing aqueous HI yielding 2-(2-phenylethyl)benzoic acid (XIII), which is then cyclized with polyphosphoric acid at 175 C afforing dibenzo[a,d]cyclohepta-1,4-diene-5-one (XIV). The ketone (XIV) is brominated with NBS in CCl4 to the bromo ketone (XV) and finally dehydrobrominated with triethylamine.
【1】
Roberts, P.J.; Castañer, J.; Cyclobenzaprine. Drugs Fut 1977, 2, 5, 299.
|
【2】
Vilani, F.J. (Schering Corp.); 5-(3'-Dimethylamino-2'-methylpropyl)dibenzocycloheptenes. US 3409640 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29151 |
5H-dibenzo[a,d]cyclohepten-5-one; Dibenzosuberenone
|
2222-33-5 |
C15H10O |
详情 | 详情
|
(X) |
11900 |
2-Benzofuran-1,3-dione;1,2-Benzenedicarboxylic Anhydride;1,2-BENZENE DICARBOXYLIC ACID ANHYDRIDE;1,2-BENZENEDICARBONIC ACID, ANHYDRIDE;1,3-DIOXOPHTHALAN;1,3-ISOBENZOFURANDIONE;o-phthalic anhydride; Phthalic anhydride |
85-44-9 |
C8H4O3 |
详情 | 详情
|
(XI) |
16148 |
Benzeneacetic acid; 2-Phenylacetic acid; Phenyl Acetic Acid
|
103-82-2 |
C8H8O2 |
详情 | 详情
|
(XII) |
40121 |
3-[(Z)-benzylidene]-2-benzofuran-1-one; Benzalphthalide; 3-[(Z)-benzylene]-1-isobenzofuranone; Benzylidenephthalide; 3-[(Z)-benzylene]-1(3H)-isobenzofuranone; 3-(Z)-Benzylidenephthalide
|
575-61-1 |
C15H10O2 |
详情 | 详情
|
(XIII) |
40122 |
2-phenethylbenzoic acid
|
4890-85-1 |
C15H14O2 |
详情 | 详情
|
(XIV) |
40123 |
10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-one; Dibenzosuberone
|
1210-35-1 |
C15H12O |
详情 | 详情
|
(XV) |
40124 |
10-bromo-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-one
|
|
C15H11BrO |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(VII) Alkylation of phenylacetic acid (VII) with allyl bromide (VIII) using lithium bis(trimethylsilyl)amide furnished 2-phenyl-4-pentenoic acid (IX). Reduction of the carboxylate group of (IX) by means of LiAlH4 and AlCl3 gave rise to alcohol (X), which was subsequently converted to triflate (XI). The triflate group of (XI) was then displaced with benzimidazole (XII) to produce adduct (XIII). Dihydroxylation of the double bond of (XIII) with N-methylmorpholine-N-oxide in the presence of OsO4, followed by oxidative cleavage with NaIO4, yielded aldehyde (XIV). Finally, aldehyde (XIV) was reductively condensed with piperidine (VI) in the presence of sodium triacetoxyborohydride.
【1】
Kim, D.; Wang, L.; Caldwell, C.G.; et al.; Design, synthesis, and SAR of heterocycle-containing human CCR5 antagonists for the treatment of HIV-1 infection. 220th ACS Natl Meet (Aug 20 2000, Washington DC) 2000, Abst MEDI 84.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
43905 |
4-nitrobenzyl allyl(4-piperidinyl)carbamate
|
|
C16H21N3O4 |
详情 |
详情
|
(VII) |
16148 |
Benzeneacetic acid; 2-Phenylacetic acid; Phenyl Acetic Acid
|
103-82-2 |
C8H8O2 |
详情 | 详情
|
(VIII) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(IX) |
44294 |
2-phenyl-4-pentenoic acid
|
|
C11H12O2 |
详情 |
详情
|
(X) |
44295 |
2-phenyl-4-penten-1-ol
|
|
C11H14O |
详情 |
详情
|
(XI) |
44296 |
2-phenyl-4-pentenyl trifluoromethanesulfonate
|
|
C12H13F3O3S |
详情 |
详情
|
(XII) |
44297 |
1H-benzimidazole
|
51-17-2 |
C7H6N2 |
详情 | 详情
|
(XIII) |
44298 |
1-(2-phenyl-4-pentenyl)-1H-benzimidazole
|
|
C18H18N2 |
详情 |
详情
|
(XIV) |
44299 |
4-(1H-benzimidazol-1-yl)-3-phenylbutanal
|
|
C17H16N2O |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(IV)
【1】
Sharma NR.Rawat GS. 2004. Synthesis of rofecoxib and study of Lactone ring stability. Asia J Chem, 16: 978~982 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19262 |
1-[4-(methylsulfanyl)phenyl]-1-ethanone;4'-Methylthioacetophenon;4’-(methylthio)acetophenone |
1778-09-2 |
C9H10OS |
详情 | 详情
|
(II) |
19263 |
1-[4-(methylsulfonyl)phenyl]-1-ethanone; 4-methylsulfonylacetophenone
|
10297-73-1 |
C9H10O3S |
详情 | 详情
|
(III) |
19264 |
2-bromo-1-[4-(methylsulfonyl)phenyl]-1-ethanone
|
|
C9H9BrO3S |
详情 |
详情
|
(IV) |
16148 |
Benzeneacetic acid; 2-Phenylacetic acid; Phenyl Acetic Acid
|
103-82-2 |
C8H8O2 |
详情 | 详情
|
(V) |
19274 |
2-[4-(methylsulfonyl)phenyl]-2-oxoethyl 2-phenylacetate
|
|
C17H16O5S |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(II)
【1】
Kim DY, Kim JG, Cho DJ, et aL. 2005. Method for preparing 3-phenyl-4-[ (4-methylsulfonyl) phenyl]-2(5H)-furanone as a cyclooxygenase-2 inhibitor. W0 2005051935(奉专利属于Yang Pharm Co, Ltd,S Korea). |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
39243 |
2-bromo-1-(4-bromophenyl)-1-ethanone
|
99-73-0 |
C8H6Br2O |
详情 | 详情
|
(II) |
16148 |
Benzeneacetic acid; 2-Phenylacetic acid; Phenyl Acetic Acid
|
103-82-2 |
C8H8O2 |
详情 | 详情
|
(III) |
66649 |
1-(4-bromophenyl)-2-(2-oxo-2-phenylethoxy)ethanone |
|
C16H13BrO3 |
详情 | 详情
|
(IV) |
66650 |
4-(4-bromophenyl)-3-phenylfuran-2(5H)-one |
|
C16H11BrO2 |
详情 | 详情
|
合成路线13
该中间体在本合成路线中的序号:
(V)
【1】
Ao GZ, Wang WD.Zhang YH. 2002.Synthesis of selective COX-2 inhibitor rofecoxib. 中国医药工业杂志, 33: 267~268(本论文作者来自于Center of Drug Discovery.China Pharmaceutical University, Nanjing, Peop Rep China) |
【2】
Desmond R, Dolling UH, Frey LF,et aL. 1998. Process of preparing phenyl heterocycles useful as COX-2 inhibitors. W0 9800416(本专利属于Merck&Co.Inc,USA) |
【3】
Therien M. Gauthier JY, Leblanc Y et aL. 2001. Syntheais of Rofecoxib, (MK 0966, Vioxx 4-(4'-methyl-sulfonylphenyl) -3-phenyl-2(5H)-furanone), a selective ancl orally active inhibitor of cycloocygeruse-2. Synthesis, (12):1778~1779(本论文作者来自于Merck Frosst Centre for Therapeutic Research,Dorval, QC, Can) |
【4】
Wu AH,Wang QH,Wang QL et al. 2002.Synthesis of new cyclooxygenase-2 inhibitor: rofcoxib.中国药物化学杂志,12: 37~38(本论文作者来自于School of Pharmaceutical Engineering,Shenyang Pharmaceutical University, Shenyang, Peop Rep China) |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19272 |
methyl phenyl sulfide; 1-(methylsulfanyl)benzene
|
100-68-5 |
C7H8S |
详情 | 详情
|
(II) |
19262 |
1-[4-(methylsulfanyl)phenyl]-1-ethanone;4'-Methylthioacetophenon;4’-(methylthio)acetophenone |
1778-09-2 |
C9H10OS |
详情 | 详情
|
(III) |
19263 |
1-[4-(methylsulfonyl)phenyl]-1-ethanone; 4-methylsulfonylacetophenone
|
10297-73-1 |
C9H10O3S |
详情 | 详情
|
(IV) |
19264 |
2-bromo-1-[4-(methylsulfonyl)phenyl]-1-ethanone
|
|
C9H9BrO3S |
详情 |
详情
|
(V) |
16148 |
Benzeneacetic acid; 2-Phenylacetic acid; Phenyl Acetic Acid
|
103-82-2 |
C8H8O2 |
详情 | 详情
|